Keyphrases
Haploidentical Transplantation
100%
Delayed Engraftment
100%
Host-versus-graft Direction
100%
HLA Epitope Mismatch
100%
Epitope
83%
Haploidentical Hematopoietic Stem Cell Transplantation
83%
Adjusted Hazard Ratio
66%
Epitope Mismatch
50%
Clinical Outcomes
33%
Relapse Risk
33%
HLA Class II
33%
Post-transplantation Cyclophosphamide (PTCy)
33%
HLAMatchmaker
33%
Neutrophils
16%
High Dose
16%
Protective Effect
16%
Risk Reduction
16%
Patient Demographics
16%
Platelets
16%
Peripheral Blood
16%
Single Center
16%
Negative Effects
16%
Engraftment
16%
Relapse-free Survival
16%
Peripheral Blood T Cells
16%
T-cell Replete
16%
HLA Eplet
16%
Time-to-Count
16%
HLA Disparity
16%
Immunology and Microbiology
Epitope
100%
Engraftment
100%
Hematopoietic Cell
41%
Cell Transplantation
41%
Cyclophosphamide
16%
T Cell
8%
Drug Megadose
8%
Allele
8%
Neutrophil
8%
Platelet
8%
Recurrence Free Survival
8%